Back to Search
MARK DEMITRACK, M.D.
M.D.
Psychiatry Physician
NPI: 1619410842Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
MD4222248(PA)
Research & Publications (19)
Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
PMID 19629020·Psychopharmacol Bull·2009
6-review
Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary.
PMID 16610962·Pharmacogenomics·2006
6-review
Clinical perspectives on antidepressant drug development: a critical discussion.
PMID 15638759·Curr Pharm Des·2005
6-review
Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
PMID 19330495·Adv Ther·2009
4-observational
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
PMID 18294022·J Clin Psychiatry·2008
2-rct
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment.
PMID 18232722·J Clin Psychiatry·2008
4-observational
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
PMID 17888885·Biol Psychiatry·2008
4-observational
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
PMID 17573044·Biol Psychiatry·2007
4-observational
Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.
PMID 15232330·J Clin Psychopharmacol·2004
3-trial
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
PMID 15589385·Eur Neuropsychopharmacol·2004
3-trial
Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome.
PMID 15157948·Brain Behav Immun·2004
3-trial
Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
PMID 12000204·J Clin Psychiatry·2002
3-trial
The tyramine pressor test may have limited sensitivity, especially in the presence of dual serotonin/norepinephrine uptake inhibition.
PMID 11927196·Neuropsychopharmacology·2002
8-other
Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
PMID 11926722·J Clin Psychiatry·2002
3-trial
What is chronic fatigue syndrome? Heterogeneity within an international multicentre study.
PMID 11531735·Aust N Z J Psychiatry·2001
4-observational
Abnormalities in response to vasopressin infusion in chronic fatigue syndrome.
PMID 11087963·Psychoneuroendocrinology·2001
8-other
The impact of restrictive entry criterion during the placebo lead-in period.
PMID 10783806·Biometrics·2000
8-other
Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial.
PMID 10759342·Int Clin Psychopharmacol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3222 PHOENIXVILLE PIKE
MALVERN, PA 19355 - Phone
- (610) 640-4202
Quick Facts
- NPI
- 1619410842
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile